Skip to main content

Table 2 HCV patient characteristics and outcome of evaluation

From: Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project

  N = 4 (100%)
Sex
 Male 2 (50%)
 Female 2 (50%)
Age (years) (mean ± SD) 59 ± 21
Migrational background
 Dutch / WE 3 (75%)
 EE/EA 1 (25%)
ALT (U/l) (mean + SD) 35 ± 18
 Normal (0-34 U/l) 3 (75%)
 > 1xULN 1 (25%)
Viral load (IU/mL) (median) 137,605
Fibrosis stage
 F0-F1 3 (75%)
 F2-F3 1 (25%)
Management advice
 No therapy 1 (25%)
 Antiviral therapy 3 (75%)
  1. WE Western Europe, EE Eastern Europe, EA Euro Asia, ALT Alanine-aminotransferase, ULN Upper limit of normal